The Department of Health and Human Services under Robert F. During his Senate confirmation hearings, Health Secretary Robert ...

In the wake of this week's meeting of a newly reconstituted federal vaccine advisory board, public health, medical, and infectious disease experts are not holding back in their reaction to the panel's ...

Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans ...

The Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP), and its eight new ...

As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked ...